HymonBio Co.,Ltd products

Hymon Respiratory Triplex Panel Test Kit applies innovative “one-step method” to solve the cumbersome problem of nucleic acid extraction for SARS-CoV-2, influenza A and influenza B viruses; The nucleic acid is automatically released in 3 minutes, with sample-to-results as short as 35 minutes. Based on MoLock (nano-antibody molecular lock technology) and dual internal standard design, it achieves high sensitivity, high specificity, and full-process monitoring. A single tube can help detect COVID-19 N and E genes, influenza A and influenza B viruses by multiplex testing.

HAEMOCERT Colorectal Cancer Screening Test has passed CE certification and is used for early colorectal cancer screening.

Hymon SARS-CoV-2 Test Kit provides in vitro detection of coronavirus SARS-CoV-2 in nasopharyngeal swab and other respiratory samples. The virus infects human and caused COVID-19.

Hymon provides a flexible, quantitative PCR respiratory detection solution for quick and sensitive clinical testing, and provide accurate detection results for some of the most common respiratory diseases. Hymon^® MULTONE^TM Respiratory Panel Test Kit adopts multiple qPCR technology and provides a combination panel for simultaneously detecting 12 different pathogens.

Hymon COVID-19 antigen rapid test kit is a lateral flow immunoassay for the qualitative detection of SARS-COV-2 antigen (nucleocapsid protein) with nasal swabs or saliva during the acute phase of infection. It only takes 15 minutes to complete the test and the test is also non-invasive. Negative results do not rule out SARS CoV-2 infection, and should not be used as the sole basis for treatment. Molecular assay may be performed if necessary.